Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.8200 (-10.96%) ($11.8200 - $11.8200) on Mon. Mar. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.86% (three month average) | RSI | 53 | Latest Price | $11.8200(-10.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 5.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(37%) ARKK(35%) IWC(35%) | Factors Impacting BCRX price | BCRX will decline at least -3.43% in a week (0% probabilities). VIXM(-20%) UUP(-15%) VXX(-7%) IGOV(-7%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.43% (StdDev 6.86%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $12.13 | 5 Day Moving Average | $12.83(-7.87%) | 10 Day Moving Average | $12.88(-8.23%) | 20 Day Moving Average | $12.13(-2.56%) | To recent high | -13.3% | To recent low | 67.8% | Market Cap | $2.085b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |